- Ticker
- AKAN
- Price
- 0.76
- Stock movement up
- +0.02 (3.12%)
- Company name
- Akanda Corp
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Drug Manufacturers-Specialty & Generic
- Market cap
- 23.41M
- Ent value
- 30.17M
- Price/Sales
- 961.75
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2022-08-25
DIVIDENDS
AKAN does not pay dividends
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 961.75 |
| Price to Book | - |
| EV to Sales | 1239.09 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 30.81M |
| EPS (TTM) | -0.10 |
| FCF per share (TTM) | -0.00 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 24.35K |
| Gross profit (TTM) | -4.00 |
| Operating income (TTM) | -597.99K |
| Net income (TTM) | -2.87M |
| EPS (TTM) | -0.10 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -0.02% |
| Operating margin (TTM) | -2456.22% |
| Profit margin (TTM) | -11776.28% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 3.50M |
| Net receivables | 242.36K |
| Total current assets | 3.98M |
| Goodwill | 0.00 |
| Intangible assets | 259.10K |
| Property, plant and equipment | 0.00 |
| Total assets | 8.05M |
| Accounts payable | 680.33K |
| Short/Current long term debt | 9.57M |
| Total current liabilities | 8.27M |
| Total liabilities | 10.25M |
| Shareholder's equity | -2.20M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -9.42K |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -9.42K |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -35.63% |
| Return on Invested Capital | 130.24% |
| Cash Return on Invested Capital | 0.43% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.75 |
| Daily high | 0.77 |
| Daily low | 0.72 |
| Daily Volume | 470K |
| All-time high | 11.81 |
| 1y analyst estimate | - |
| Beta | - |
| EPS (TTM) | -0.10 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| AKAN | S&P500 | |
| Current price drop from All-time high | -93.56% | -12.18% |
| Highest price drop | -93.94% | -56.47% |
| Date of highest drop | 23 Aug 2022 | 9 Mar 2009 |
| Avg drop from high | -66.77% | -11.38% |
| Avg time to new high | 23 days | 12 days |
| Max time to new high | 88 days | 1805 days |
COMPANY DETAILS
Marketcap
23.41M
Marketcap category
Small-cap
Description
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Employees
107
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
LONDON, September 26, 2022--International medical cannabis platform company Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN) expects to take a leading position in the fast-growing German medica...
September 26, 2022
LONDON, September 13, 2022--International medical cannabis platform company Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN) today announced an exclusive license agreement with iconic internati...
September 13, 2022
LONDON, September 08, 2022--International cannabis company Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN) today announced that Terry Booth, the founder of Aurora Cannabis Inc. ("Aurora Cannab...
September 8, 2022
LONDON, September 07, 2022--International medical cannabis platform company Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN) today announced that Chief Executive Officer Tej Virk will attend th...
September 7, 2022
Cannabis producer ramps up Portugal operation to distribute in Germany amid rising industry interest in the region.
August 30, 2022
LONDON, August 24, 2022--International medical cannabis platform company Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN) today announced that it has appointed Tom Flow to the role of Chief Ope...
August 24, 2022
LONDON, August 09, 2022--International medical cannabis platform company Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN) today announced it has signed a multi-year supply agreement with Europe...
August 9, 2022
FRANKFURT AM MAIN & LONDON, August 09, 2022--Akanda Corp. ("Akanda") (NASDAQ: AKAN) and Cansativa GmbH ("Cansativa Group") today jointly announced a new cooperation that will soon allow German pharmac...
August 9, 2022
LONDON, July 27, 2022--Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN), an international medical cannabis platform company, today announced that the High Court of Lesotho (the "Lesotho Court")...
July 27, 2022
Akanda Corp. ("Akanda") (NASDAQ: AKAN) and Tetra Bio-Pharma ("Tetra") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), today jointly announced that Akanda will supply Tetra with pharmaceutical grade cannabis fl...
July 12, 2022
Next page